Annexon, Inc.
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Trading Arrangements of Section 16 Reporting Persons.
During the three months ended September 30, 2026, the following directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted, amended or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.
| Types of Trading Arrangement | |||||
|---|---|---|---|---|---|
| Name and Position · Action · Adoption Date · Rule 10b5-1* · Non-Rule 10b5-1** · Total Shares of Common Stock to Be Sold · Total Shares of Common Stock to Be Purchased · Expiration Date | |||||
| Bill Carlson, M.D., Director | Adopt | 07/03/2026 | X | 102,000 | 4/30/27 |
- Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(a) of Regulation S-K under the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.